A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Study sponsor: PTC Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2031-02-28Estimated
Enrollment · participants56Estimated
Source updated2026-10-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.